Amesite (AMST) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
6 Feb, 2026Product and market overview
Develops and markets AI-driven solutions for B2C and B2B, focusing on healthcare and professional learning.
NurseMagic™ app provides real-time support for healthcare professionals, reducing charting time and improving communication.
Achieved $2.4M in revenue since product launch, with high learner completion rates (96-98%).
Integrated with Microsoft and first in EdTech to use ChatGPT.
Serves a large and growing market, including 5.2M US RNs and 26K care facilities.
Technology and differentiation
NurseMagic™ AI scores 91% on USMLE and 93% on NCLEX prep, trained on real-world data and nursing ethics.
Meets HIPAA requirements with secure integration and 24/7 threat monitoring.
Infrastructure supports integration with existing systems and continuous model refinement.
Over 20 proprietary models and 100+ APIs integrated, with frequent feature upgrades.
Revenue growth and market traction
B2C: Over 10,000 free users, subscriptions launched Dec 2024, users in 50 states and 21 countries.
B2B: Enterprise pilot programs launched, first revenue within 5 months, targeting $5.2B in annual revenue from outreach.
Achieves profitability with fewer than 30,000 B2C or 17,000 B2B users.
Automated B2C purchases and straightforward B2B contracts.
Latest events from Amesite
- Auditors flagged going concern risks; offering led by Laidlaw & Company (UK) Ltd.AMST
Registration filing26 May 2026 - Revenue increased and net loss narrowed, but going concern risks persist despite new capital.AMST
Q3 202618 May 2026 - AI healthcare firm offers 4.8M shares for resale, with viability dependent on warrant exercise proceeds.AMST
Registration filing12 May 2026 - Healthcare AI firm offers shares and warrants to fund growth amid ongoing losses and compliance risks.AMST
Registration filing20 Apr 2026 - NurseMagic's rapid adoption and scalable AI platform drive strong revenue and market growth.AMST
Investor presentation6 Feb 2026 - Revenue surged but losses persist; going concern and Nasdaq compliance risks remain.AMST
Q2 20266 Feb 2026 - Director and auditor approved; NurseMagic gains traction; strong insider investment.AMST
AGM 202510 Jan 2026 - NurseMagic's rapid adoption and scalable sales model position the company for profitable growth in 2025.AMST
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Flexible $100M shelf registration targets growth in AI-driven education and healthcare solutions.AMST
Registration Filing16 Dec 2025